These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2107895)

  • 1. Prolonged endometrial stimulation associated with oestradiol implants.
    Gangar KF; Fraser D; Whitehead MI; Cust MP
    BMJ; 1990 Feb; 300(6722):436-8. PubMed ID: 2107895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
    Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
    BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous transdermal oestrogen and interrupted progestogen as a novel bleed-free regimen of hormone replacement therapy for postmenopausal women.
    Cameron ST; Critchley HO; Glasier AF; Williams AR; Baird DT
    Br J Obstet Gynaecol; 1997 Oct; 104(10):1184-90. PubMed ID: 9332998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dose-ranging study of the use of cyclical dydrogesterone with continuous 17 beta oestradiol.
    Burch DJ; Spowart KJ; Jesinger DK; Randall S; Smith SK
    Br J Obstet Gynaecol; 1995 Mar; 102(3):243-8. PubMed ID: 7794851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can endometrial protection be inferred from the bleeding pattern on combined cyclical hormone replacement therapy.
    Burch D; Bieshuevel E; Smith S; Fox H
    Maturitas; 2000 Feb; 34(2):155-60. PubMed ID: 10714910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women.
    Leather AT; Savvas M; Studd JW
    Obstet Gynecol; 1991 Dec; 78(6):1008-10. PubMed ID: 1658699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial and menstrual response to subcutaneous oestradiol and testosterone implants and continuous oral progestogen therapy in post-menopausal women.
    Magos AL; Brincat M; O'Dowd T; Wardle PJ; Schlesinger P; Studd JW
    Maturitas; 1985 Nov; 7(4):297-302. PubMed ID: 4079826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial factors under treatment with oestrogen and oestrogen/progestogen combinations.
    Aylward M; Maddock J; Parker A; Protheroe DA; Ward A
    Postgrad Med J; 1978; 54 Suppl 2():74-81. PubMed ID: 740584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial morphology and bleeding patterns as a function of progestogen supplementation.
    Sturdee DW
    Int J Fertil Menopausal Stud; 1996; 41(1):22-8. PubMed ID: 8673153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long oestradiol replacement in an oocyte donation programme.
    Remohí J; Gutiérrez A; Cano F; Ruiz A; Simón C; Pellicer A
    Hum Reprod; 1995 Jun; 10(6):1387-91. PubMed ID: 7593502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of Norplant implants.
    Faúndes A; Alvarez F; Brache V; Cochón L
    Hum Reprod; 1998 Jan; 13(1):188-91. PubMed ID: 9512255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of percutaneous oestradiol gels in postmenopausal hormone replacement therapy on clinical symptoms and endometrium.
    Foidart JM; Béliard A; Hedon B; Ochsenbein E; Bernard AM; Bergeron C; Thomas JL
    Br J Obstet Gynaecol; 1997 Mar; 104(3):305-10. PubMed ID: 9091006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal oestrogen replacement therapy with subcutaneous oestradiol implants.
    Suhonen S; Sipinen S; Lähteenmäki P; Laine H; Rainio J; Arko H
    Maturitas; 1993 Mar; 16(2):123-31. PubMed ID: 8483424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel statistical approach to analysis of bleeding patterns during continuous hormone replacement therapy.
    Sporrong T; Samsioe G; Larsen S; Mattsson LA
    Maturitas; 1989 Sep; 11(3):209-15. PubMed ID: 2593864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of the addition of nomegestrol acetate to post-menopausal oestrogen therapy.
    Fraser DI; Padwick ML; Whitehead MI; White J; Ryder TA; Pryse-Davies J
    Maturitas; 1989 Mar; 11(1):21-34. PubMed ID: 2725335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultra low dose continuous combined hormone replacement therapy with 0.5mg 17beta-oestradiol and 2.5mg dydrogesterone: protection of the endometrium and amenorrhoea rate.
    Bergeron C; Nogales FF; Rechberger T; Tatarchjuk T; Zipfel L
    Maturitas; 2010 Jun; 66(2):201-5. PubMed ID: 20378287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintained bone density at advanced ages after long term treatment with low dose oestradiol implants.
    Naessén T; Persson I; Thor L; Mallmin H; Ljunghall S; Bergström R
    Br J Obstet Gynaecol; 1993 May; 100(5):454-9. PubMed ID: 8518246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absent correlation between vaginal bleeding and oestradiol levels or endometrial morphology during tibolone use in early postmenopausal women.
    Berning B; van Kuijk C; Bennink HJ; Fauser BC
    Maturitas; 2000 Apr; 35(1):81-8. PubMed ID: 10802404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A first study to compare two dosages of dydrogesterone in opposing the 50 mg oestradiol implant.
    Rees M; Leather A; Pryse-Davies J; Collins SA; Barlow DH; Studd JW
    Maturitas; 1991 Dec; 14(1):9-15. PubMed ID: 1791775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.